First Command Advisory Services, Inc. Gilead Sciences, Inc. Transaction History
First Command Advisory Services, Inc.
- $10.3 Billion
- Q1 2025
A detailed history of First Command Advisory Services, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, First Command Advisory Services, Inc. holds 47 shares of GILD stock, worth $5,191. This represents 0.0% of its overall portfolio holdings.
Number of Shares
47
Previous 26
80.77%
Holding current value
$5,191
Previous $2,000
150.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding GILD
# of Institutions
2,287Shares Held
997MCall Options Held
9.62MPut Options Held
10M-
Black Rock Inc. New York, NY121MShares$13.3 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$13 Billion0.25% of portfolio
-
State Street Corp Boston, MA59.5MShares$6.57 Billion0.28% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$6.03 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$5.91 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $138B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...